SUNNYVALE, Calif.--(BUSINESS WIRE)--July 12, 2006--IntraOp Medical Corporation (OTCBB: IOPM - News), the developer of a mobile electron-beam accelerator for delivering intraoperative electron radiation therapy (IOERT), announces that a recently published report of a study group of the Italian Association of Radiotherapy (AIRO) concluded that IOERT treatment markedly improves clinical outcomes for patients with pancreatic cancer. Pancreatic cancer is one of the most deadly forms of cancer, claiming the lives of over 31,000 Americans each year.
